Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC SARS-CoV-2-IN-86 (andrographolide derivative) | 368866-07-3 | MFCD02683117 | 99.4% | 466.53 g·mol⁻¹ | C26H30N2O6 | 250 MG
Supplier: Medchemexpress LLC 250MGHYW024485
SARS-CoV-2-IN-86 is an andrographolide-derived small-molecule inhibitor of SARS-CoV-2 methyltransferases nsp14 and nsp16, characterized for in vitro activity and low predicted toxicity; supplied for research use with manufacturer guidance on solubility and storage.
- Inhibits SARS-CoV-2 methyltransferases nsp14 and nsp16.
- Andrographolide derivative scaffold suitable for antiviral research.
- High purity (≈99.4%) suitable for biochemical and cellular assays.
- Soluble in DMSO at ~50 mg/mL; may require ultrasonic and warming.
- Stable as powder when stored at -20°C or 4°C according to guidance.
- Available in multiple pack sizes to support different study scales.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?